LOS ANGELES — Homeopathic medicine maker Hyland’s Inc. has named Les Hamilton to succeed Dale Nepsa as president.
Hyland’s said Thursday that Nepsa has retired after 25 years at Hyland’s. Hamilton, who had served as executive vice president since July 2013, will lead the company’s sales division, ensuring strategic alignment with its food, drug and mass retailers and natural food store clients.
“I have had a great four years already with Hyland’s,” Hamilton said in a statement. “I am excited to help lead this next phase of the company’s very long history in the United States. I believe there are many more opportunities and my team is ready to take on the challenge of pursuing them.”
Hamilton joined Hyland’s in October 2011 as vice president of sales, coming to the company from The Emerson Group, where he served as field sales manager for seven years. At Emerson, Hamilton’s accounts included the Target Corp.’s over-the-counter products business. Before Emerson, Hamilton spent nearly 10 years in various posts at Target, including category manager for a number of pharmacy categories and all OTC private-label items.
Hyland’s noted that Hamilton also holds leadership roles at several industry association groups, including the Consumer Healthcare Products Association (CHPA), National Association of Chain Drug Stores (NACDS) and Global Market Development Center (GMDC).
“Les’s demonstrated leadership and experience in our markets ensure that we’re helping to meet our customers’ needs and make our consumers lives better, through his established relationships and understanding of how consumers shop,” stated J.P. Borneman, chief executive officer of Hyland’s. “Les joined the Hyland’s family in 2011 as vice president of sales and has helped drive company growth that has overindexed the industry. We look forward to this next phase of the company’s long history.”
Nepsa has been a key growth driver at Hyland’s during his 25-year tenure leading the sales division, the company said. Among his accomplishments was the introduction of Hyland’s Teething Tablets into the food, drug and mass retail channel. He has also served as a key member of the executive committee, helping guide the strategic direction of the company.
“We cannot be more grateful for Dale’s leadership and commitment to Hyland’s during the last 25 years,” Borneman added. “His contributions will be long-lasting and have created a strong foundation upon which we can continue to grow.”